Αρχική World News Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis... World News Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 Από Ogkologos - 1 Ιουλίου, 2025 722 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR Scientists find cells in centre of tumours are most likely to... 18 Μαΐου, 2021 Pazopanib Shows Promise for Children, Adults with Soft Tissue Sarcomas 9 Σεπτεμβρίου, 2020 ‘Family Haven’ Gives Homeless Parents & Their Kids Hope And A... 29 Δεκεμβρίου, 2021 How the National Cancer Act Has Made a Difference in Cancer... 18 Φεβρουαρίου, 2021 Φόρτωση περισσοτέρων HOT NEWS How Does COVID-19 Affect People with Cancer? NCCAPS Will Help Find... November is National Family Caregivers Month Adding Retifanlimab To Chemotherapy Provides OS Benefit over Chemotherapy In First-Line... Joining the dots: How our new research data strategy will unlock...